Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-04

FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Solco Healthcare US,LLC)

View source ↗

Summary

FDA approved a supplemental application for lisdexamfetamine dimesylate capsules submitted by Solco Healthcare US, LLC. The approval covers lisdexamfetamine dim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisdexamfetamine dimesylate capsules (lisdexamfetamine dimesylate)

Snippet

SUPPL AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE CAPSULES)